ZAI Lab competitors
ZAI Lab's competitors include MyoKardia, Athersys, Neurocrine Biosciences and Ironwood Pharmaceuticals
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing and commercializing innovative medicines. |  MyoKardia MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. |  Athersys Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications. |  Neurocrine Biosciences Neurocrine Biosciences is a biotechnology company focused on neurologic, psychiatric and endocrine-related disorders. |  Ironwood Pharmaceuticals Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases. |
Founding Date | Founding Date 2013 | Founding Date 2012 | Founding Date 1995 | Founding Date 1992 | Founding Date N/A |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Shanghai, CN HQ Suzhou, CN Chaoyang, CN | Locations South San Francisco, US HQ | Locations Cleveland, US HQ Canton, US | Locations San Diego, US HQ | Locations Cambridge, US HQ |
Employees | Employees 21 | Employees 1024% increase | Employees 60 | Employees 400 | Employees 674 |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 2 b | Valuation ($) 275.9 m | Valuation ($) 9.1 b | Valuation ($) 3 b |
Facebook likes | Facebook likes N/A | Facebook likes N/A | Facebook likes 475 | Facebook likes N/A | Facebook likes 18 |
Twitter followers | Twitter followers N/A | Twitter followers 387 | Twitter followers 953 | Twitter followers N/A | Twitter followers 3.1 k |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $22.5m (FY, 2017) | Revenue (est.) $3.7m (FY, 2017) | Revenue (est.) $15m (FY, 2016) | Revenue (est.) $274m (FY, 2016) |
Net income | Net income ($37.5m) (FY, 2016) | Net income ($46m) (FY, 2017) | Net income N/A | Net income ($141.1m) (FY, 2016) | Net income ($81.7m) (FY, 2016) |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 4 (FY, 2017) | Patents (US) 21 (FY, 2016) | Patents (US) N/A | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised $ 160m | Total funding raised $ 98m | Total funding raised $ 9m | Total funding raised $ 10m | Total funding raised $ 284m |
For sources of this data, please see the company profileDownload Excel
View company profiles
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
View companyAthersys
HQ
Cleveland, US
Employees
60
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
View companyNeurocrine Biosciences
HQ
San Diego, US
Employees
400
Neurocrine Biosciences is a biotechnology company focused on neurologic, psychiatric and endocrine-related disorders.
View companyIronwood Pharmaceuticals
HQ
Cambridge, US
Employees
674
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
View company